The CCK-8 results indicated that TNF-α treatment significantly promoted RA-FLS proliferation, whereas knockdown of USP5 or treatment with 2-DG (an inhibitor of glycolysis) inhibited this effect (Fig. 2B). This evidence concerns the gene USP5 and rheumatoid arthritis.